Every tenth patient with a cardiac pacemaker or implantable cardioverter-defibrillator
implanted is expected to have at least one lead problem in his lifetime. However …

Aims Left bundle branch pacing (LBBP) has been shown to better maintain electrical
synchrony compared with right ventricular pacing (RVP), but little is known about its impact …

Background: Transvenous lead extraction (TLE) is the preferred management strategy for
complications related to cardiac implantable electronic devices. TLE sometimes can cause …

Infections involving cardiac implantable electronic devices (CIEDs) occur at different times
after device-related procedures. The aim of this study was to investigate the timing of onset …

Introduction The increasing number of cardiac implantable electronic device complications
represents a current problem. Abandoned leads are difficult to manage, even because …

Background The constant interaction between intracardiac leads and the heart and veins
results in excessive accumulation of fibrous connective tissue around the leads. The extent …

Background Leadless pacemakers (LPs) have proven safe and effective, but device
revisions remain necessary. Either replacing the LP or implanting a new adjacent LP is …

Background: A lead-reactive fibrous capsule (FC) identified by ultrasounds as an atrial or
ventricular lead thickness of more than 1 mm above the vendor-declared lead diameter (TL) …

The demand for cardiac implantable electronic devices for arrhythmia therapy is still
unabated and rising. Despite onward optimizations, lead-related problems such as …

Background Lead‐dependent infective endocarditis (LDIE) is a serious and insidious
infective disease spreading along the leads to valve leaflets and endocardial surface. LDIE …